- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Endometrial Neoplasms"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Endometrial Neoplasms" (171 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03276013 | Not yet recruiting | Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
51 | Female | 18 Years and older (Adult, Senior) | NCT03276013 | VHIO17001 | TOPIC | January 2018 | January 2020 | May 2020 | September 8, 2017 | September 8, 2017 | ||
2 | NCT02822833 | Recruiting | The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
100 | Female | 18 Years and older (Adult, Senior) | NCT02822833 | 04 | July 2016 | June 2017 | June 2017 | July 4, 2016 | September 13, 2016 |
|
||
3 | NCT02725268 | Recruiting | Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
242 | Female | 18 Years and older (Adult, Senior) | NCT02725268 | C31004 U1111-1168-1824 2014-005394-37 02725268 |
April 1, 2016 | February 28, 2019 | September 30, 2019 | March 31, 2016 | April 17, 2018 |
|
||
4 | NCT02690259 | Recruiting | Sentinel Lymph Node Detection in Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
375 | Female | 18 Years and older (Adult, Senior) | NCT02690259 | RegionSkaneKKLund | June 2014 | June 2019 | June 2021 | February 24, 2016 | September 5, 2017 |
|
||
5 | NCT01820884 | Recruiting | The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma |
|
|
Interventional | Not Applicable |
|
Other |
|
|
240 | Female | 18 Years to 50 Years (Adult) | NCT01820884 | 2012-GYN/EC-02 | EC-02 | November 2012 | December 2017 | December 2018 | March 29, 2013 | October 10, 2017 |
|
|
6 | NCT01820858 | Recruiting | The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma |
|
|
Interventional | Phase 3 |
|
Other |
|
|
300 | Female | 18 Years to 65 Years (Adult) | NCT01820858 | 2012-GYN/EC-01 | EC-01 | November 2012 | December 2017 | December 2018 | March 29, 2013 | October 10, 2017 |
|
|
7 | NCT03498924 | Recruiting New |
Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue |
|
|
Observational |
|
Other |
|
|
80 | Female | 18 Years and older (Adult, Senior) | NCT03498924 | STUDY17104 | August 1, 2017 | August 1, 2018 | August 1, 2020 | April 17, 2018 | April 17, 2018 |
|
|||
8 | NCT03241914 | Recruiting | Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
40 | Female | 18 Years to 45 Years (Adult) | NCT03241914 | 2017-30-2 | July 4, 2017 | July 3, 2020 | July 3, 2020 | August 8, 2017 | October 24, 2017 |
|
||
9 | NCT03291275 | Recruiting | Survival Outcomes of Uterine Malignancies in Chinese Population |
|
|
Observational |
|
Other |
|
|
10000 | Female | Child, Adult, Senior | NCT03291275 | SOUM-1 | September 1, 2017 | September 1, 2022 | September 1, 2023 | September 25, 2017 | February 8, 2018 |
|
|||
10 | NCT03112733 | Recruiting | Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers |
|
|
Observational |
|
Other |
|
|
180 | Female | 18 Years to 70 Years (Adult, Senior) | NCT03112733 | 83045809-604.01.02 TAB-2017-22506 |
April 4, 2017 | January 2018 | April 2018 | April 13, 2017 | January 29, 2018 |
|
|||
11 | NCT03184350 | Recruiting | Adjuvant Protontherapy of Cervical and Endometrial Carcinomas |
|
|
Interventional | Not Applicable |
|
Other |
|
|
25 | Female | 18 Years to 80 Years (Adult, Senior) | NCT03184350 | APROVE | APROVE | June 2017 | June 2019 | June 2021 | June 12, 2017 | June 12, 2017 |
|
|
12 | NCT03291106 | Recruiting | Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer |
|
|
Observational |
|
Other |
|
|
1500 | Female | 18 Years and older (Adult, Senior) | NCT03291106 | Lynch-PUMCH | September 1, 2017 | October 1, 2019 | October 1, 2020 | September 25, 2017 | September 25, 2017 |
|
|||
13 | NCT00250770 | Recruiting | Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis |
|
Observational |
|
Other |
|
750 | Female | Child, Adult, Senior | NCT00250770 | CSF-1 | January 1998 | January 2022 | January 2022 | November 8, 2005 | May 12, 2016 |
|
|||||
14 | NCT03207061 | Recruiting | Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? |
|
|
Interventional | Not Applicable |
|
Other |
|
|
500 | Female | 18 Years and older (Adult, Senior) | NCT03207061 | 16HH3687 3D Ultrasound EC | June 13, 2017 | December 20, 2018 | January 20, 2019 | July 2, 2017 | January 30, 2018 |
|
||
15 | NCT03207126 | Recruiting | Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | Female | 18 Years and older (Adult, Senior) | NCT03207126 | 16HH3687 USS guided biopsy EC | June 13, 2017 | December 20, 2018 | January 20, 2019 | July 2, 2017 | December 22, 2017 |
|
||
16 | NCT03207074 | Recruiting | Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | Female | 18 Years and older (Adult, Senior) | NCT03207074 | 16HH3687 iKnife EC | June 13, 2017 | June 20, 2019 | October 20, 2019 | July 2, 2017 | December 22, 2017 |
|
||
17 | NCT02494791 | Recruiting | Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
915 | All | 18 Years to 70 Years (Adult, Senior) | NCT02494791 | 14-8533CE | LS2 | July 2015 | July 2019 | July 2025 | July 10, 2015 | April 19, 2016 |
|
|
18 | NCT03270995 | Recruiting | Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
144 | Female | 18 Years and older (Adult, Senior) | NCT03270995 | RCT FCR | October 2014 | December 1, 2018 | December 1, 2018 | September 1, 2017 | March 22, 2018 |
|
||
19 | NCT03489473 | Not yet recruiting New |
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment |
|
|
Observational |
|
Other |
|
|
40 | Female | 40 Years and older (Adult, Senior) | NCT03489473 | FESPET | FESPET | June 1, 2018 | June 1, 2019 | December 1, 2019 | April 5, 2018 | April 5, 2018 | |||
20 | NCT03485729 | Recruiting New |
ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | Female | 18 Years and older (Adult, Senior) | NCT03485729 | ONC012 | March 21, 2018 | March 21, 2020 | March 21, 2021 | April 2, 2018 | April 2, 2018 |
|
||
21 | NCT03469674 | Recruiting | PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
500 | Female | 16 Years and older (Child, Adult, Senior) | NCT03469674 | P16.054 UL2011-5336 ISRCTN11659025 NTR5841 |
PORTEC-4a | June 10, 2016 | December 2021 | December 2023 | March 19, 2018 | March 19, 2018 |
|
|
22 | NCT03466788 | Not yet recruiting | Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
45 | Female | 18 Years and older (Adult, Senior) | NCT03466788 | EndoQOL | EndoQOL | March 2018 | March 2019 | September 2019 | March 15, 2018 | March 16, 2018 |
|
|
23 | NCT03456791 | Recruiting | Human Epididymis Protein 4 in Endometrial Carcinoma |
|
|
Observational |
|
Other |
|
|
84 | Female | 45 Years to 70 Years (Adult, Senior) | NCT03456791 | 4 | December 1, 2017 | June 2018 | December 2018 | March 7, 2018 | March 7, 2018 |
|
|||
24 | NCT03438474 | Not yet recruiting | Endometrial Cancer Lymphadenectomy Trial |
|
|
Interventional | Not Applicable |
|
Other |
|
|
640 | Female | 18 Years to 75 Years (Adult, Senior) | NCT03438474 | AGO-OP.6 KKS 228 | ECLAT | March 15, 2018 | February 15, 2028 | February 15, 2029 | February 19, 2018 | February 20, 2018 |
|
|
25 | NCT03366480 | Recruiting | A Study to Assess the Efficacy and Safety of ABTL0812 |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry / Other |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT03366480 | ABT-C5-2016 2016-001352-21 |
Endolung | December 1, 2016 | December 14, 2017 | November 15, 2018 | December 8, 2017 | December 13, 2017 |
|
|
26 | NCT03366051 | Recruiting | Sentinel Node Mapping in High Risk Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
162 | Female | 18 Years to 75 Years (Adult, Senior) | NCT03366051 | 2.392.088 | ALICE | December 20, 2017 | December 20, 2021 | December 20, 2024 | December 8, 2017 | December 11, 2017 |
|
|
27 | NCT03324958 | Not yet recruiting | VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. |
|
|
Interventional | Phase 3 |
|
Other |
|
|
170 | Female | 18 Years and older (Adult, Senior) | NCT03324958 | 2017-0501 2017-A01919-44 |
Vire-Brachy | November 1, 2017 | May 1, 2019 | May 1, 2019 | October 30, 2017 | October 30, 2017 |
|
|
28 | NCT03298100 | Recruiting | Risk Scoring Model for Endometrial Cancer |
|
|
Observational |
|
Other |
|
|
100 | Female | 40 Years and older (Adult, Senior) | NCT03298100 | 3176af | Cohort | September 26, 2017 | June 30, 2018 | September 30, 2018 | September 29, 2017 | September 29, 2017 |
|
||
29 | NCT03189446 | Recruiting | Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
50 | Female | 18 Years to 99 Years (Adult, Senior) | NCT03189446 | 7964 | October 2, 2017 | June 1, 2022 | June 1, 2023 | June 16, 2017 | October 31, 2017 |
|
||
30 | NCT03115593 | Not yet recruiting | Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
360 | Female | Child, Adult, Senior | NCT03115593 | CHUB-Hystocor | March 2018 | March 2020 | March 2020 | April 14, 2017 | January 23, 2018 |
|
||
31 | NCT03099499 | Recruiting | Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
36 | Female | 18 Years and older (Adult, Senior) | NCT03099499 | GYN-106 | June 8, 2017 | October 1, 2019 | October 1, 2020 | April 4, 2017 | July 14, 2017 |
|
||
32 | NCT03095664 | Recruiting | Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors |
|
|
Interventional | Not Applicable |
|
Other |
|
|
286 | Female | 20 Years to 69 Years (Adult, Senior) | NCT03095664 | 55155116.9.0000.5274 | November 2016 | November 2023 | November 2023 | March 30, 2017 | April 4, 2017 |
|
||
33 | NCT03077698 | Recruiting | An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
72 | Female | 18 Years and older (Adult, Senior) | NCT03077698 | VX-EC-2-02 | June 14, 2017 | January 31, 2021 | January 31, 2021 | March 13, 2017 | March 1, 2018 |
|
||
34 | NCT03024398 | Not yet recruiting | Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial Cancer |
|
Observational |
|
Other |
|
|
50 | Female | 18 Years and older (Adult, Senior) | NCT03024398 | 6492 | Sentimetre | January 2017 | January 2019 | January 2019 | January 18, 2017 | January 18, 2017 |
|
|||
35 | NCT03016338 | Recruiting | Study of Niraparib in Recurrent Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
44 | Female | 18 Years and older (Adult, Senior) | NCT03016338 | NEC | November 6, 2017 | March 2022 | September 2022 | January 10, 2017 | March 23, 2018 |
|
||
36 | NCT02987881 | Recruiting | Endometrial Cancer Diet and Exercise |
|
|
Interventional | Not Applicable |
|
Other |
|
|
15 | Female | 18 Years and older (Adult, Senior) | NCT02987881 | Pro00074542 | February 1, 2017 | July 2019 | July 2019 | December 9, 2016 | October 26, 2017 |
|
||
37 | NCT02912572 | Recruiting | Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
70 | Female | 18 Years and older (Adult, Senior) | NCT02912572 | 16-322 | November 14, 2016 | April 2020 | April 2024 | September 23, 2016 | June 7, 2017 |
|
||
38 | NCT02899793 | Recruiting | Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
25 | Female | 18 Years to 100 Years (Adult, Senior) | NCT02899793 | 1605017712 | September 2016 | June 2018 | June 2018 | September 14, 2016 | October 9, 2017 |
|
||
39 | NCT02834988 | Recruiting | Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1700 | Female | 18 Years and older (Adult, Senior) | NCT02834988 | 20151012 | July 28, 2016 | January 2020 | June 2020 | July 15, 2016 | December 7, 2017 |
|
||
40 | NCT02826291 | Recruiting | SLNM in Endometrial Cancer Combined With OSNA |
|
|
Observational |
|
Other |
|
|
31 | Female | 18 Years and older (Adult, Senior) | NCT02826291 | OSNA-EC-01 | SLNM/OSNA | March 2016 | December 2017 | December 2017 | July 7, 2016 | February 1, 2017 |
|
||
41 | NCT02774395 | Not yet recruiting | Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine |
|
Observational |
|
Other |
|
|
40 | Female | 18 Years and older (Adult, Senior) | NCT02774395 | 15-AOI-09 | May 2016 | May 2018 | January 2019 | May 17, 2016 | May 17, 2016 |
|
||||
42 | NCT02767362 | Recruiting | A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
24 | Female | 18 Years to 75 Years (Adult, Senior) | NCT02767362 | LCCC 1514 | November 2015 | November 2018 | November 2019 | May 10, 2016 | September 13, 2017 |
|
||
43 | NCT02762214 | Recruiting | Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY |
|
|
Interventional | Phase 3 |
|
Other |
|
|
154 | Female | 18 Years to 80 Years (Adult, Senior) | NCT02762214 | RoManHy | RoManHy | October 2015 | October 2016 | October 2017 | May 4, 2016 | May 4, 2016 |
|
|
44 | NCT02755844 | Not yet recruiting | Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
36 | Female | 18 Years to 81 Years (Adult, Senior) | NCT02755844 | 69HCL15_0321 | ENDOLA | April 2016 | April 2018 | November 2019 | April 29, 2016 | April 29, 2016 |
|
|
45 | NCT02730429 | Recruiting | Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
78 | Female | 18 Years and older (Adult, Senior) | NCT02730429 | ENGOT-EN3-NSGO/PALEO | February 15, 2017 | December 2020 | December 2022 | April 6, 2016 | April 4, 2017 |
|
||
46 | NCT02730416 | Recruiting | Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
148 | Female | 18 Years and older (Adult, Senior) | NCT02730416 | ENGOT-EN1/FANDANGO | November 2016 | July 2021 | July 2022 | April 6, 2016 | March 30, 2017 |
|
||
47 | NCT02684318 | Recruiting | Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / Industry |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT02684318 | POLA/ACOG1401 | July 2015 | July 2019 | October 2019 | February 18, 2016 | June 22, 2017 |
|
||
48 | NCT02684227 | Recruiting | Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
69 | Female | 18 Years and older (Adult, Senior) | NCT02684227 | 2015-0723 NCI-2016-00562 |
August 2016 | August 2019 | August 2020 | February 17, 2016 | March 21, 2018 |
|
||
49 | NCT02665962 | Recruiting | Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | Female | 18 Years and older (Adult, Senior) | NCT02665962 | UPCC 09815 | July 2015 | July 2017 | January 28, 2016 | September 26, 2016 |
|
|||
50 | NCT02658565 | Recruiting | Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation |
|
|
Interventional | Not Applicable |
|
Other |
|
|
400 | Female | 18 Years to 100 Years (Adult, Senior) | NCT02658565 | MCC-15-GYN-150 | January 2016 | December 2019 | December 2024 | January 20, 2016 | January 16, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.